Skip to main content

Find Clinical Trials

Home
Conditions
Polyneuropathies

Clinical trial condition

Polyneuropathies

Explore clinical trials studying Polyneuropathies. Study availability and eligibility vary by location and protocol.

430 public trials 123 recruiting studies

Refine in advanced search Browse all conditions

Polyneuropathies trial results

Completed

Disability Severity Scale (DSI) and Hereditary Motor and Sensory Neuropathy Overall Disability Scale (HMSN-R-ODS)

NCT02194010

Conditions: Charcot Marie Tooth Disease, Charcot-Marie-Tooth Disease, Congenital Abnormalities, +11 more
Locations: University of Iowa Iowa City, Iowa, United States

University of Rochester Medical Center Rochester, New York, United States

National Hospital of Neurology and Neurosurgery London, United Kingdom

View Trial Details

Completed

A Trial of Cognitive Behavioral Therapy in Familial Dysautonomia

NCT03013777

Conditions: Anxiety Disorders, Autonomic Nervous System Diseases, Autosomal Recessive Disease, +20 more
Locations: New York University School of Medicine New York, United States

View Trial Details

Completed

Suprascapular Neuropathy in the Setting of Rotator Cuff Tears: Results of Arthroscopic Treatment

NCT02318381

Conditions: Charcot-Marie-Tooth Disease, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +16 more
Locations: First Orthopaedic Department of Aristotle University of Thessaloniki, 'G. Papanikolaou' Hospital Thessaloniki, Exohi, Greece

View Trial Details

Completed

Intrapartum Vancomycin for Group B Streptococcus (GBS) Prophylaxis

NCT02143154

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +14 more
Locations: Women & Infants Hospital Providence, Rhode Island, United States

View Trial Details

Completed

Extension Study of Maintenance Treatment With Subcutaneous Immunoglobulin (IgPro20) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

NCT02027701

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
Locations: Site Reference 8400181 Birmingham, Alabama, United States

Site Reference 8400167 Los Angeles, California, United States

Site Reference 8400166 Kansas City, Kansas, United States

Site Reference 8400169 New York, United States

View all 33 locations

View Trial Details

Completed

L-Serine Supplementation in Hereditary Sensory Neuropathy Type 1

NCT01733407

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +9 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

UMass Medical Center Worcester, Massachusetts, United States

View Trial Details

Completed

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Treatment With Subcutaneous Immunoglobulin (IgPro20)

NCT01545076

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
Locations: Site reference 8400181 Birmingham, Alabama, United States

Site reference 8400173 Phoenix, Arizona, United States

Site reference 8400172 Phoenix, Arizona, United States

Site reference 8400167 Los Angeles, California, United States

View all 91 locations

View Trial Details

Completed

Phase I Trial of Oral PX-866

NCT00726583

Conditions: Advanced Solid Tumors, Carcinoma, Congenital Abnormalities, +13 more
Locations: University of Colorado Health Sciences Center Aurora, Colorado, United States

M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Phase 1 and 2 Study of PX-866 and Cetuximab

NCT01252628

Conditions: Carcinoma, Carcinoma, Squamous Cell, Colonic Diseases, +30 more
Locations: Birmingham Hematology and Oncology Assocs. Birmingham, Alabama, United States

University of Alabama Birmingham Birmingham, Alabama, United States

Southwest Cancer Care Escondido, California, United States

Monterey Bay Oncology Monterey, California, United States

View all 40 locations

View Trial Details

Completed

Study of PX-866 and Docetaxel in Solid Tumors

NCT01204099

Conditions: Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +26 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Southwest Cancer Care Escondido, California, United States

Bay Area Cancer Research Group, LLC Pleasant Hill, California, United States

University of Colorado Cancer Center Aurora, Colorado, United States

View all 33 locations

View Trial Details